Comparison

Leramilimab Biosimilar - Research Grade European Partner

Item no. ICH5066-50MG
Manufacturer IchorBio
Amount 50mg
Category
Type Biosimilars
Applications FA
Specific against Human
Purity >95% by SDS-PAGE
ECLASS 10.1 42030590
ECLASS 11.0 42030590
UNSPSC 12352203
Available
Specificity Detects human LAG3. This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Leramilimab. This product is for research use only.
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Concentration
5mg/ml
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purification method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: Out of stock
Questions about this Product?
 
Close